Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salbutamol - nebuliser solution - 2.5 mg/2.5 millilitre(s) - selective beta-2-adrenoreceptor agonists; salbutamol

Singapoo - Kiingereza - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - salbutamol sulphate eqv salbutamol - powder, metered - 200 mcg/inhalation - salbutamol sulphate eqv salbutamol 200 mcg/inhalation

Marekani - Kiingereza - NLM (National Library of Medicine)

direct rx - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - 1.1 bronchospasm ventolin hfa inhalation aerosol is indicated for the treatment or prevention of bronchospasm in patients aged 4 years and older with reversible obstructive airway disease. 1.2 exercise-induced bronchospasm ventolin hfa is indicated for the prevention of exercise-induced bronchospasm in patients aged 4 years and older. ventolin hfa is contraindicated in patients with a history of hypersensitivity to any of the ingredients [see warnings and precautions (5.6), description (11)]. 8.1 pregnancy pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to asthma medications during pregnancy. for more information, contact the mothertobaby pregnancy studies conducted by the organization of teratology information specialists at 1‑877-311-8972 or visit https://mothertobaby.org/ongoing-study/asthma/. risk summary there are no randomized clinical studies of use of albuterol sulfate during pregnancy. available data from epidemiological studies and

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

pinewood healthcare - salbutamol sulfate - oral solution - 400microgram/1ml

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

glaxosmithkline (gsk) - salbutamol - solution for injection - 0.5 mg/ml

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

glaxo saudi arabia ltd., saudi arabia - salbutamol - solution for injection - 0.5 mg/ml

Kanada - Kiingereza - Health Canada

glaxosmithkline inc - salbutamol (salbutamol sulfate) - solution - 1mg - salbutamol (salbutamol sulfate) 1mg - selective beta 2-adrenergic agonists

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Panama - Kiingereza - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

glaxosmithkline mexico, s.a. de c.v. de mexico - salbutamol - salbutamol....0.040 g

Panama - Kiingereza - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

glaxosmithkline (ireland) limited - salbutamol (sulfato) - salbutamol (sulfato)....2.00 mg